Bone marrow-sparing radiotherapy in women with cervical cancer treated with radiochemotherapy
Clinical Snapshot
PICO Framework
| P — Population | Women with locally advanced cervical cancer receiving concurrent chemoradiotherapy |
| I — Intervention | Bone marrow-sparing radiotherapy techniques |
| C — Comparator | Non-bone marrow-sparing (conventional) radiotherapy |
| O — Outcomes | Acute haematologic toxicity, acute gastrointestinal and genitourinary toxicity, bone marrow dose-volume parameters |
Bottom Line
This Cochrane protocol outlines a systematic review comparing bone marrow-sparing versus conventional radiotherapy in women with locally advanced cervical cancer receiving concurrent chemoradiotherapy. The protocol addresses a clinically important question about reducing acute haematologic toxicity while maintaining treatment efficacy. The focus on dose-volume relationships could provide practical guidance for radiation oncologists implementing bone marrow-sparing techniques. However, as this is only a protocol, no evidence synthesis or clinical recommendations are yet available. The completed review will be valuable for informing evidence-based practice in cervical cancer radiotherapy, particularly relevant for Australian centres with advanced radiotherapy capabilities seeking to optimise treatment toxicity profiles.
Key Findings
P Value: Not applicable - protocol only
Effect Size: Not applicable - protocol only
Primary Outcome: Protocol stage - no results available
Nnt Or Sensitivity: Not applicable - protocol only
Confidence Interval: Not applicable - protocol only
Clinical Application
Bone marrow-sparing techniques require advanced radiotherapy planning systems and expertise available in major Australian cancer centres Relevant to Australian practice where IMRT/VMAT capabilities exist; aligns with Cancer Australia cervical cancer treatment guidelines emphasising toxicity reduction Women with locally advanced cervical cancer receiving concurrent chemoradiotherapy in tertiary cancer centres
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary objective To evaluate the benefits and harms of bone marrow-sparing radiotherapy compared with non-bone marrow-sparing radiotherapy in women with locally advanced cervical cancer treated with concurrent chemoradiotherapy. Secondary objectives To investigate whether effects differ according to clinical, histopathological, and technical characteristics, focusing on: acute haematologic toxicity; acute gastrointestinal and genitourinary toxicity; and bone marrow dose-volume parameters associated with acute haematologic toxicity, including exploration of dose-volume ranges relevant for clinical implementation.
References
- 1.Cantidio, F. S., Costa Diniz, P. H., Gil, G., & Silva-Filho, A. L. (2026). Bone marrow-sparing radiotherapy in women with cervical cancer treated with radiochemotherapy. The Cochrane Database of Systematic Reviews. https://doi.org/10.1016/j.jclinepi.2013.08.005
Related Research
Medical physics
Reference-Free large language model agents for physician-guided radiotherapy treatment planning
2 Aug 2026
Cancer medicine
Applications of Artificial Intelligence in Cancer Diagnosis and Treatment
1 Aug 2026
Acta oncologica (Stockholm, Sweden)
User perceptions of machine learning models as decision support for colorectal cancer multidisciplinary team conferences (AID-SIM-2): a qualitative simulation study.
1 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service